Freeman Chris
SEC CIK 1871615 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GH | Guardant Health, Inc. | Chief Commercial Off | 129.0K | — | $16.92M | 53 | 2022-06-15 | 2026-08-10 |
Most active insiders at GH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Talasaz AmirAli | Co-CEO, Dir | — | $84.25M |
| 2 | Eltoukhy Helmy | Co-CEO, Dir | — | $22.03M |
| 3 | Freeman Chris | Chief Commercial Off | — | $16.92M |
| 4 | Monroe Terilyn J. | CHRO | — | $15.95M |
| 5 | Bell Michael Brian | CFO | — | $8.81M |
| 6 | CLARK IAN T | Dir | — | $6.06M |
| 7 | Kalia Kumud | CIO | $78.5K | $5.91M |
| 8 | Chudova Darya | CTO | — | $4.36M |
| 9 | Saia John G. | CLO | — | $4.25M |
| 10 | Krognes Steve E. | Dir | — | $2.40M |
Transactions 53
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-11 18:22 | 2026-08-10 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $74.09 | +63.6K | 129.0K | +97% | +$4.71M |
| DM | 2026-08-11 18:22 | 2026-08-10 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | S - Sale+OE | $169.58 | -63.6K | 65.4K | -49% | -$10.79M |
| DM | 2026-07-02 18:11 | 2026-07-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +7,414 | 68.5K | +12% | $0 |
| D | 2026-07-02 18:11 | 2026-07-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $170.77 | -3,141 | 65.4K | -5% | -$536.4K |
| D | 2026-06-16 16:37 | 2026-06-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +1,402 | 61.7K | +2% | $0 |
| D | 2026-06-16 16:37 | 2026-06-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $129.82 | -594 | 61.1K | -1.0% | -$77.1K |
| D | 2026-05-26 17:38 | 2026-05-22 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $32.86 | +24.4K | 84.4K | +41% | +$802.0K |
| D | 2026-05-26 17:38 | 2026-05-22 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | S - Sale+OE | $118.67 | -24.4K | 60.0K | -29% | -$2.90M |
| DM | 2026-04-02 17:22 | 2026-04-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +11.2K | 64.8K | +21% | $0 |
| D | 2026-04-02 17:22 | 2026-04-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $91.15 | -4,750 | 60.0K | -7% | -$433.0K |
| DM | 2026-03-17 | 2026-03-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +16.8K | 59.3K | +40% | $0 |
| D | 2026-03-17 | 2026-03-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $85.49 | -7,127 | 53.6K | -12% | -$609.3K |
| D | 2026-01-05 | 2026-01-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $102.14 | -10.2K | 43.9K | -19% | -$1.04M |
| DM | 2026-01-05 | 2026-01-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +27.2K | 54.0K | +102% | $0 |
| D | 2025-12-17 | 2025-12-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +1,402 | 27.4K | +5% | $0 |
| D | 2025-12-17 | 2025-12-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $102.67 | -594 | 26.8K | -2% | -$61.0K |
| M | 2025-12-08 | 2025-12-05 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | S - Sale | $103.06 | -31.5K | 35.9K | -47% | -$3.24M |
| DM | 2025-10-02 | 2025-10-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +13.6K | 51.6K | +36% | $0 |
| D | 2025-10-02 | 2025-10-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $62.65 | -5,740 | 57.4K | -9% | -$359.6K |
| D | 2025-09-17 | 2025-09-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +1,402 | 50.2K | +3% | $0 |
| D | 2025-09-17 | 2025-09-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $54.79 | -594 | 49.6K | -1% | -$32.5K |
| DM | 2025-07-02 | 2025-07-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +3,596 | 50.4K | +8% | $0 |
| D | 2025-07-02 | 2025-07-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $50.71 | -1,532 | 48.8K | -3% | -$77.7K |
| DM | 2025-06-16 | 2025-06-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +6,281 | 48.0K | +15% | $0 |
| D | 2025-06-16 | 2025-06-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $49.29 | -2,675 | 46.8K | -5% | -$131.9K |
| D | 2025-04-02 | 2025-04-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $42.47 | -1,106 | 42.3K | -3% | -$47.0K |
| DM | 2025-04-02 | 2025-04-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +3,595 | 41.7K | +9% | $0 |
| D | 2025-03-18 | 2025-03-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +1,401 | 40.2K | +4% | $0 |
| D | 2025-03-18 | 2025-03-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $42.89 | -387 | 39.8K | -1.0% | -$16.6K |
| D | 2025-03-04 | 2025-03-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +5,686 | 40.4K | +16% | $0 |
| D | 2025-03-04 | 2025-03-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $42.55 | -1,566 | 38.8K | -4% | -$66.6K |
| DM | 2025-01-03 | 2025-01-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +3,595 | 35.9K | +11% | $0 |
| D | 2025-01-03 | 2025-01-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $30.55 | -1,183 | 34.7K | -3% | -$36.1K |
| D | 2024-12-16 | 2024-12-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $34.76 | -597 | 32.3K | -2% | -$20.8K |
| D | 2024-12-16 | 2024-12-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +1,402 | 32.9K | +4% | $0 |
| D | 2024-10-02 | 2024-10-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $22.12 | -3,620 | 31.5K | -10% | -$80.1K |
| DM | 2024-10-02 | 2024-10-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +8,498 | 28.5K | +42% | $0 |
| D | 2024-09-16 | 2024-09-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +1,402 | 27.2K | +5% | $0 |
| D | 2024-09-16 | 2024-09-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $26.79 | -597 | 26.6K | -2% | -$16.0K |
| D | 2024-07-02 | 2024-07-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $28.26 | -758 | 25.8K | -3% | -$21.4K |
| D | 2024-07-02 | 2024-07-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +1,928 | 26.5K | +8% | $0 |
| DM | 2024-06-17 | 2024-06-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +10.4K | 21.9K | +90% | $0 |
| D | 2024-06-17 | 2024-06-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $30.21 | -2,870 | 24.6K | -10% | -$86.7K |
| D | 2024-04-02 | 2024-04-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +1,929 | 16.5K | +13% | $0 |
| D | 2024-04-02 | 2024-04-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $20.25 | -531 | 16.0K | -3% | -$10.8K |
| D | 2024-01-03 | 2024-01-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $27.05 | -634 | 14.6K | -4% | -$17.1K |
| D | 2024-01-03 | 2024-01-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +1,928 | 15.2K | +15% | $0 |
| D | 2023-10-02 | 2023-10-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +7,713 | 15.4K | +100% | $0 |
| D | 2023-10-02 | 2023-10-01 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $29.64 | -2,128 | 13.3K | -14% | -$63.1K |
| D | 2023-06-16 | 2023-06-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +4,879 | 9,040 | +117% | $0 |
| D | 2023-06-16 | 2023-06-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $37.86 | -1,346 | 7,694 | -15% | -$51.0K |
| D | 2022-06-17 | 2022-06-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | F - Tax | $38.42 | -1,688 | 3,191 | -35% | -$64.9K |
| D | 2022-06-17 | 2022-06-15 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +4,879 | 4,879 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations